cyr-064
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 26, 2023 (NCT06019000)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06498687 | Phase 1 | Dec 31, 2024 | University of Nebraska |
| NCT06019000 | Phase 2 | Sep 26, 2023 | Cyrano Therapeutics, Inc., The University of Texas, Dallas |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cyrano Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2023 |
| The University of Texas, Dallas | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Nebraska | Academic/Hospital | 1 | 1 | 1 | 2024 |
3 organizations
Page 1 / 1